Clinical Trial Update: Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs) [Phase 2]

View source ↗

Summary

This document reports that Zanzalintinib is being evaluated as maintenance therapy in high-grade neuroendocrine neoplasms in a Phase 2 trial that is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Neuroendocrine Neoplasm

Drugs mentioned

• Zanzalintinib (Zanzalintinib)

Snippet

Sponsor: Washington University School of Medicine | Conditions: High Grade Neuroendocrine Neoplasms | Phase 2 | Status: RECRUITING